Nebivolol Comp. Ratiopharm (Hydrochlorothiazide, Nebivolol)

Nebivolol and hydrochlorothiazide, the active ingredients in Nebivolol Comp. Ratiopharm, are a beta‑blocker and a thiazide diuretic presented as tablets for oral use. They lower blood pressure in adult patients with hypertension, combining vasodilation and diuresis to achieve effective control.

GNH USA supplies Nebivolol Comp. Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol Comp. Ratiopharm is used in the management of hypertension, targeting elevated systemic blood pressure.

Essential hypertension: reduces systolic and diastolic pressure in patients with primary high blood pressure. Secondary hypertension: assists in controlling blood pressure when hypertension is caused by another condition. Hypertension with fluid retention: provides combined beta‑blockade and diuretic action to manage blood pressure and excess fluid.

Nebivolol Comp. Ratiopharm may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Dizziness - Headache - Fatigue - Increased urinary frequency

Serious or Rare Side Effects: - Severe hypotension - Electrolyte disturbances (e.g., low potassium) - Allergic reactions such as rash or angioedema - Acute kidney injury

When prescribing Nebivolol Comp. Ratiopharm, clinicians should observe several precautionary measures to ensure safe use.

Monitor blood pressure: verify adequate control and avoid excessive drops. Assess renal function: adjust use in patients with impaired kidney function. Check electrolytes: watch for potassium or sodium imbalances. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Use caution in asthma: β1‑selectivity may still affect bronchial tone. Store at room temperature: keep in the original container, protect from moisture.

Nebivolol Comp. Ratiopharm can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Concomitant use with other antihypertensives may cause excessive hypotension. - Potassium‑sparing diuretics can lead to hyperkalemia when combined with hydrochlorothiazide. - Non‑steroidal anti‑inflammatory drugs may reduce the diuretic effect of hydrochlorothiazide.

Moderate Interactions (Monitor Closely): - Calcium channel blockers may enhance the blood‑pressure‑lowering effect. - Beta‑agonist inhalers can diminish nebivolol’s β‑blockade. - Lithium therapy may have increased serum levels.